These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20488756)
1. Coeliac disease autoantibodies mediate significant inhibition of tissue transglutaminase. Byrne G; Feighery C; Jackson J; Kelly J Clin Immunol; 2010 Sep; 136(3):426-31. PubMed ID: 20488756 [TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding. Byrne G; Ryan F; Jackson J; Feighery C; Kelly J Gut; 2007 Mar; 56(3):336-41. PubMed ID: 16935926 [TBL] [Abstract][Full Text] [Related]
3. Binding of autoantibodies to the core region of tissue transglutaminase is a feature of paediatric coeliac disease. Comerford R; Byrne G; Feighery C; Kelly J J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):445-50. PubMed ID: 22383027 [TBL] [Abstract][Full Text] [Related]
4. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Agardh D; Lynch K; Brundin C; Ivarsson SA; Lernmark A; Cilio CM Clin Exp Immunol; 2006 Apr; 144(1):67-75. PubMed ID: 16542367 [TBL] [Abstract][Full Text] [Related]
5. Pathomechanisms in celiac disease. Dieterich W; Esslinger B; Schuppan D Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421 [TBL] [Abstract][Full Text] [Related]
6. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing. Sandström O; Rosén A; Lagerqvist C; Carlsson A; Hernell O; Högberg L; Ivarsson A J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):472-6. PubMed ID: 23783015 [TBL] [Abstract][Full Text] [Related]
7. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509 [TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase in celiac disease: role of autoantibodies. Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979 [TBL] [Abstract][Full Text] [Related]
10. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179 [TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase--the key player in celiac disease: a review. Reif S; Lerner A Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648 [TBL] [Abstract][Full Text] [Related]